{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:50:19Z","timestamp":1790286619626,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1007\/bf02785869","type":"journal-article","created":{"date-parts":[[2007,12,19]],"date-time":"2007-12-19T11:54:32Z","timestamp":1198065272000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Distribution of 2-chloro-2\u2032-deoxyadenosine, 2-chloro-2\u2032-arabino-fluoro-2\u2032-deoxyadenosine, Fludarabine and Cytarabine in mice: a whole-body autoradiography study"],"prefix":"10.1007","volume":"16","author":[{"given":"Synn\u00f6ve","family":"Lindemalm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Liliemark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt S","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freidoun","family":"Albertioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"BF02785869_CR1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2165\/00003495-199346050-00007","volume":"46","author":"HM Bryson","year":"1993","unstructured":"Bryson HM, Sorkin EM. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies [Review].Drugs 1993;46: 872\u2013894.","journal-title":"Drugs"},{"key":"BF02785869_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/jm00080a029","volume":"35","author":"J Montgomery","year":"1992","unstructured":"Montgomery J, Shortnacy-Flower A, Clayton Set al. Synthesis and biological activity of 2\u2032-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.J Med Chem 1992;35: 397\u2013401.","journal-title":"J Med Chem"},{"key":"BF02785869_CR3","first-page":"2386","volume":"51","author":"W Parker","year":"1991","unstructured":"Parker W, Shaddix S, Chang Cet al. Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polumerases by its 5\u2032-triphosphate.Cancer Res 1991;51: 2386\u20132394.","journal-title":"Cancer Res"},{"key":"BF02785869_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s002800050889","volume":"43","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Kanazawa J, Akinaga Set al. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration.Cancer Chemother Pharmacol 1999;43: 233\u2013240.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02785869_CR5","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1073\/pnas.89.7.2970","volume":"89","author":"D Carson","year":"1992","unstructured":"Carson D, Wasson B, Esparza Let al. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2\u2032-arabinofluoro-2\u2032-deoxyadenosine.Proc Natl Acad Sci USA 1992;89: 2970\u20132974.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02785869_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1124\/mol.53.2.270","volume":"53","author":"A Herrstr\u00f6m Sj\u00f6berg","year":"1998","unstructured":"Herrstr\u00f6m Sj\u00f6berg A, Wang L, Eriksson S. Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs.Mol. Pharmacol 1998;53: 270\u2013273.","journal-title":"Mol. Pharmacol"},{"key":"BF02785869_CR7","series-title":"Recent Advances in Chemotherapy","volume-title":"2-Chloro-2\u2032-deoxyadenosine Phosphorylation by deoxyguanosine kinase in crude extracts of malignant human brain tissue","author":"L Wang","year":"1993","unstructured":"Wang L, Karlsson A, Mathiesen T, Eriksson S. 2-Chloro-2\u2032-deoxyadenosine Phosphorylation by deoxyguanosine kinase in crude extracts of malignant human brain tissue.Recent Advances in Chemotherapy, Washington, DC: Am. Soc. Microbiol., 1993."},{"key":"BF02785869_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/10826079508009280","volume":"18","author":"V Reichelova","year":"1995","unstructured":"Reichelova V, Liliemark J, Albertioni F Stucture-activity relationships of 2-chloro-2\u2032-arabino-fluoro-2\u2032-deoxyadenosine and related analogues: protein binding, lipophilicity, and retention in reversed-phase LC.J Liq Chromatogr 1995;18: 1123\u20131135.","journal-title":"J Liq Chromatogr"},{"key":"BF02785869_CR9","first-page":"199","volume":"229","author":"HC van Prroijen","year":"1977","unstructured":"van Prroijen HC Vierwinden G, Wessel J, Haanen C. Cytosine arabinoside binding to human plasma proteins.Arch Int Pharmacodyn Ther 1977;229: 199\u2013205.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BF02785869_CR10","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1200\/JCO.1995.13.9.2431","volume":"13","author":"BD Cheson","year":"1995","unstructured":"Cheson BD. Infectious and immunosuppressive complications of purine analog therapy. [Review].J Clin Oncol 1995;13: 2431\u20132448.","journal-title":"J Clin Oncol"},{"key":"BF02785869_CR11","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1200\/JCO.1994.12.10.2216","volume":"12","author":"BD Cheson","year":"1994","unstructured":"Cheson BD, Vena DA, Foss FM, Sorensen, JM. Neurotoxicity of purine analogs: a review. [Review].J Clin Oncol 1994;12: 2216\u20132228.","journal-title":"J Clin Oncol"},{"key":"BF02785869_CR12","first-page":"19","volume":"72","author":"S Toyoshima","year":"1981","unstructured":"Toyoshima S, Fukuma M, Seto Yet al. In vivo distribution of 14C-labeled N4-behenoyl-1-beta-D-arabinofuranosylcytosine in mice.Gann 1981;72: 19\u201329.","journal-title":"Gann"},{"key":"BF02785869_CR13","first-page":"2847","volume":"55","author":"C Xie","year":"1995","unstructured":"Xie C, Plunkett W. Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabnofuranosyl)-adenine in human lymphoblastoid cells.Cancer Res 1995;55: 2847\u20132852.","journal-title":"Cancer Res"},{"key":"BF02785869_CR14","doi-asserted-by":"crossref","unstructured":"Ullberg S, Larsson B, Tj\u00e4lve H.Autoradiography 1982; 55\u2013108.","DOI":"10.1201\/9780429283505-4"},{"key":"BF02785869_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0160-5402(90)90027-I","volume":"24","author":"R d'Argy","year":"1990","unstructured":"d'Argy R, Sperber GO, Larsson BS, Ullberg S. Computerassisted quantification and image processing of whole-body autoradiograms.J Pharmacol Methods 1990;24: 165\u2013181.","journal-title":"J Pharmacol Methods"},{"key":"BF02785869_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.1995.13.4.989","volume":"13","author":"G Juliusson","year":"1995","unstructured":"Juliusson G, Heldal D Hippe Eet al. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.J Clin Oncol 1995;13: 989\u2013995.","journal-title":"J Clin Oncol"},{"key":"BF02785869_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199004193221605","volume":"322","author":"LD Piro","year":"1990","unstructured":"Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.E Engl J Med 1990;322: 1117\u20131121.","journal-title":"E Engl J Med"},{"key":"BF02785869_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(94)91046-4","volume":"344","author":"JC Sipe","year":"1994","unstructured":"Sipe JC, Romine JS, Koziol JAet al. Cladribine in treatment of chronic progressive multiple sclerosis.Lancet 1994;344: 9\u201313.","journal-title":"Lancet"},{"key":"BF02785869_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1200\/JCO.1992.10.3.364","volume":"10","author":"V Sanatana","year":"1992","unstructured":"Sanatana V, Mirro J, Kearns Cet al. 2-Chlrodeoxyadeno-sine produces a high rate of complete hematologic remissions in relapsed acure myeloid leukemia.J Clin Oncol 1992;10: 364\u2013370.","journal-title":"J Clin Oncol"},{"key":"BF02785869_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0005-2736(75)90259-X","volume":"394","author":"E Cornford","year":"1975","unstructured":"Cornford E, Oldendorf W. Independent blood-brain barrier transport system for nucleic acid precursors.Biochim Biophys Acta 1975;394: 211\u2013219.","journal-title":"Biochim Biophys Acta"},{"key":"BF02785869_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1471-4159.1982.tb07968.x","volume":"39","author":"R Spector","year":"1982","unstructured":"Spector R, Berlinger W. Localization and mechanism of thymidine transport in the central nervous system.J Neurochem 1982;39: 837\u2013841.","journal-title":"J Neurochem"},{"key":"BF02785869_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/095632029700800105","volume":"8","author":"N Borg","year":"1997","unstructured":"Borg N, Zhou X, Johansson Net al. Distribution to the brain and protein binding of 3\u2032 and 5-substitited 2\u2032, 3\u2032-dideoxyuridine derivatives, studied by microdialysis.Antivir Chem Chemother 1997;8: 47\u201353.","journal-title":"Antivir Chem Chemother"},{"key":"BF02785869_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/BF00685803","volume":"36","author":"V Reichelova","year":"1995","unstructured":"Reichelova V, Juliusson G, Spasokoukotskaja Tet al. Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a phase I pharmacologically directed dose-escalation concept for 2-chloro-2\u2032-deoxyadenosine.Cancer Chemother Pharmacol 1995;36: 524\u2013529.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02785869_CR24","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/0006-2952(91)90522-7","volume":"42","author":"A Habteyesus","year":"1991","unstructured":"Habteyesus A Nordenskj\u00f6ld A Bohman C, Eriksson S. Deoxynucleoside phosphorylating enzymes in monkey and human tissue show great similarities, while mouse deoxycytidine kinase has a different substrate specificity.Biochem Pharmacol 1991;42: 1829\u20131836.","journal-title":"Biochem Pharmacol"},{"key":"BF02785869_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng0795-279","volume":"10","author":"AA Migchielsen","year":"1995","unstructured":"Migchielsen AA, Breuer ML, van Roon MAet al. Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death.Nat Genet 1995;10 279\u2013287.","journal-title":"Nat Genet"},{"key":"BF02785869_CR26","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1073\/pnas.92.9.3673","volume":"92","author":"M Wakamiya","year":"1995","unstructured":"Wakamiya M, Blackburn MR, Jurecic Ret al. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice.Proc Natl Acad Sci USA 1995;92: 3673\u20133677.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02785869_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/art.1780381112","volume":"38","author":"B Eibschutz","year":"1995","unstructured":"Eibschutz B, Baird SM, Weisman MHet al. Oral 2-chlorodeoxyadenosine in psoriatic arthritis. A preliminary report.Arthritis Rheum 1995;38: 1604\u20131609.","journal-title":"Arthritis Rheum"},{"key":"BF02785869_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood.V80.3.587.587","volume":"80","author":"A Saven","year":"1992","unstructured":"Saven A, Carrera CJ, Carson DAet al. 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.Blood 1992;80: 587\u2013592.","journal-title":"Blood"},{"key":"BF02785869_CR29","first-page":"676","volume":"37","author":"T Doi","year":"1996","unstructured":"Doi T, Sakamaki S, Koike Ket al. CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma.Rinsho Ketsueki 1996;37: 676\u2013681.","journal-title":"Rinsho Ketsueki"},{"key":"BF02785869_CR30","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1200\/JCO.1995.13.9.2476","volume":"13","author":"AI Richards","year":"1995","unstructured":"Richards AI. Response of meningeal Waldenstrom's macroglobulinemia to 2-chlorodeoxyadenosine.J Clin Oncol 1995;13: 2476.","journal-title":"J Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02785869.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02785869\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02785869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02785869.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T04:55:29Z","timestamp":1702616129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02785869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["BF02785869"],"URL":"https:\/\/doi.org\/10.1007\/bf02785869","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]},"assertion":[{"value":"11 February 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 1999","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}